Sign up Australia
Proactive Investors - Run By Investors For Investors

Imperial Brands invests in medical cannabis research company

The size of the investment in biotech company, Oxford Cannabinoid Technologies, was not disclosed by the FTSE 100 tobacco firm
Medicinal cannabis
Imperial appointed an expert in medicinal cannabis to its board of directors last year

Imperial Brands PLC (LON:IMB) said its subsidiary, Imperial Brands Ventures, will invest in a British biotech company researching how marijuana can be used in medicine.

The FTSE 100-tobacco company did not disclose the size of the stake it would be taking in the company, Oxford Cannabinoid Technologies, but the investment follows a previous move last year when Imperial appointed an expert in medicinal cannabis to its board of directors.

READ: Imperial Brands shares jump as it reports ‘significant progress’ in next generation products

The announcement also comes a day after the US Food and Drug Administration (FDA) approved the use of a cannabis-based drug for the first time, a move seen as opening floodgates for more research into the medicinal properties of cannabis.

The investment forms part of a wider trend among tobacco companies, who are trying to diversify their product ranges outside of traditional tobacco products such as cigarettes in order to maintain market share.

In mid-afternoon trading Thursday, Imperial Brands shares were up 1.6% at 2,779p.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full IMB profile View Profile

Imperial Brands Timeline

Related Articles

Real Good food
September 28 2018
New chief executive Hugh Cawley said the company is seeing the benefits of its restructuring

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use